CAH Q1 Earnings Call Highlights Raised Outlook and Specialty Growth

Cardinal Health (CAH) raised its fiscal 2027 EPS guidance to $12.80-$13.00 after reporting Q1 earnings of $3.26 per share, beating estimates. The company benefited from strong specialty pharmaceutical demand (18% revenue growth), generics performance, and renewed contracts covering nearly two-thirds of revenues. However, the medical segment faced headwinds with profit declining 28% due to elevated petroleum costs.